Prostate Cancer - Results from #25640

Criteria and endpoints in advanced prostate cancer - Abstract June 8, 2012

Lifestyle and dietary factors in the prevention of lethal prostate cancer - Abstract June 8, 2012

Stimulation of a non-functioning pituitary macroadenoma after administration of goserelin acetate for locally advanced prostate cancer causing a sustained elevation in PSA and testosterone - Abstract June 8, 2012

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer - Abstract June 8, 2012

The FinnProstate Study VII: Intermittent versus continuous androgen deprivation in patients with advanced prostate cancer - Abstract June 8, 2012

Pre-treatment risk stratification of prostate cancer patients: A critical review - Abstract June 7, 2012

The need for, and utilization of prostate-bed radiotherapy after radical prostatectomy for patients with prostate cancer in British Columbia - Abstract June 7, 2012

Management of advanced prostate cancer in elderly patients - Abstract June 7, 2012

Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer - Abstract June 7, 2012

Validating the interval to biochemical failure for the identification of potentially lethal prostate cancer - Abstract June 7, 2012

A community-driven intervention for prostate cancer screening in African Americans - Abstract June 7, 2012

The integrated proactive surveillance system for prostate cancer - Abstract June 7, 2012

Transperineal prostate MR elastography: Initial in vivo results - Abstract June 7, 2012

Clinical features and prognostic factors for patients with bone metastases from prostate cancer - Abstract June 7, 2012

Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance - Abstract June 7, 2012

Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: Is transrectal ultrasound suitable to determine which patients should undergo active surveillance? - Abstract June 7, 2012

Prostate-specific antigen kinetics as a surrogate endpoint in clinical trials of metastatic castration-resistant prostate cancer: A review - Abstract June 7, 2012

Intermittent hormonal therapy in the treatment of metastatic prostate cancer: A randomized trial - Abstract June 7, 2012

Patient-reported quality of life during radiation treatment for localized prostate cancer: Results from a prospective phase II trial - Abstract June 7, 2012

Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: An open randomised phase 3 trial - Abstract June 7, 2012

Page 1283 of 1434